How are OCUL covered call max profit and max loss calculated?

Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the OCUL covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 156.72%), the computed maximum profit is $226.00 per contract and the computed maximum loss is -$823.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a OCUL covered call?

The breakeven for the OCUL covered call priced on this page is roughly $8.24 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OCUL market-implied 1-standard-deviation expected move is approximately 44.93%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current OCUL implied volatility affect this covered call?

OCUL ATM IV is at 156.72% with IV rank near 34.14%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

OCUL Covered Call Strategy

OCUL (Ocular Therapeutix, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a proprietary bioresorbable hydrogel technology to address a range of eye diseases and conditions. The company currently offers two key products: ReSure Sealant, an ophthalmic device designed to prevent fluid leakage from corneal incisions after cataract surgery, and DEXTENZA, a dexamethasone-based ophthalmic insert used to manage post-surgical inflammation and pain in the eye, as well as to treat allergic conjunctivitis. In addition to their commercial offerings, Ocular Therapeutix is actively developing several product candidates in various clinical stages, including: OTX-TKI, an axitinib intravitreal implant in Phase 1 clinical trials for wet age-related macular degeneration (AMD) and other retinal diseases. OTX-TIC, a travoprost intracameral implant, currently in Phase 2 studies for open-angle glaucoma and ocular hypertension. OTX-CSI, a cyclosporine intracanalicular insert that has successfully completed Phase 2 clinical trials for dry eye disease.

OCUL (Ocular Therapeutix, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.15B, a beta of 0.90 versus the broader market, a 52-week range of 6.23-16.44, average daily share volume of 3.2M, a public-listing history dating back to 2014, approximately 274 full-time employees. These structural characteristics shape how OCUL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.90 places OCUL roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a covered call on OCUL?

A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.

Current OCUL snapshot

As of June 30, 2026, spot at $9.93, ATM IV 156.72%, IV rank 34.14%, expected move 44.93%. The covered call on OCUL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 31-day expiry.

Why this covered call structure on OCUL specifically: OCUL IV at 156.72% is mid-range versus its 1-year history, so the credit collected on a OCUL covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 44.93% (roughly $4.46 on the underlying). The 31-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OCUL expiries trade a higher absolute premium for lower per-day decay. Position sizing on OCUL should anchor to the underlying notional of $9.93 per share and to the trader's directional view on OCUL stock.

OCUL covered call setup

The OCUL covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OCUL near $9.93, the first option leg uses a $10.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OCUL chain at a 31-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OCUL shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 100 shares	Stock	$9.93	long
Sell 1	Call	$10.50	$1.69

OCUL covered call risk and reward

Net Premium / Debit: -$824.00
Max Profit (per contract): $226.00
Max Loss (per contract): -$823.00
Breakeven(s): $8.24
Risk / Reward Ratio: 0.275

Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.

OCUL covered call payoff curve

Modeled P&L at expiration across a range of underlying prices for the covered call on OCUL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	-$823.00
$2.20	-77.8%	-$603.55
$4.40	-55.7%	-$384.11
$6.59	-33.6%	-$164.66
$8.79	-11.5%	+$54.79
$10.98	+10.6%	+$226.00
$13.18	+32.7%	+$226.00
$15.37	+54.8%	+$226.00
$17.57	+76.9%	+$226.00
$19.76	+99.0%	+$226.00

When traders use covered call on OCUL

Covered calls on OCUL are an income strategy run on existing OCUL stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.

OCUL thesis for this covered call

The market-implied 1-standard-deviation range for OCUL extends from approximately $5.47 on the downside to $14.39 on the upside. A OCUL covered call collects premium on an existing long OCUL position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether OCUL will breach that level within the expiration window. Current OCUL IV rank near 34.14% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on OCUL should anchor more to the directional view and the expected-move geometry. As a Healthcare name, OCUL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OCUL-specific events.

OCUL covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OCUL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OCUL alongside the broader basket even when OCUL-specific fundamentals are unchanged. Short-premium structures like a covered call on OCUL carry tail risk when realized volatility exceeds the implied move; review historical OCUL earnings reactions and macro stress periods before sizing. Always rebuild the position from current OCUL chain quotes before placing a trade.

Frequently asked questions

What is a covered call on OCUL?: A covered call on OCUL is the covered call strategy applied to OCUL (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With OCUL stock trading near $9.93, the strikes shown on this page are snapped to the nearest listed OCUL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are OCUL covered call max profit and max loss calculated?: Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the OCUL covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 156.72%), the computed maximum profit is $226.00 per contract and the computed maximum loss is -$823.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a OCUL covered call?: The breakeven for the OCUL covered call priced on this page is roughly $8.24 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OCUL market-implied 1-standard-deviation expected move is approximately 44.93%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a covered call on OCUL?: Covered calls on OCUL are an income strategy run on existing OCUL stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
How does current OCUL implied volatility affect this covered call?: OCUL ATM IV is at 156.72% with IV rank near 34.14%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.